BioSpace News Archive

Genetown

Synageva BioPharma to Present at the Morgan Stanley Global Healthcare Conference

September 3, 2013
·
1 min read
IN-TIME Study Shows Significant Reduction in All-Cause Mortality in ICD and CRT-D Patients With BIOTRONIK SE & Co.KG Home Monitoring®

September 3, 2013
·
3 min read
Drug Development

Amgen, Cytokinetics, Inc. Heart Failure Drug Misses Phase 2 Goals; CYTK Stock Plummets -27.13% at Market Close (September 3, 2013)

September 3, 2013
·
14 min read
Business

New Seattle Biopharmaceutical Company Formed, Rain BioScience

September 3, 2013
·
1 min read
Drug Development

Jennerex, Inc. Announces That Its Phase 2 Study of Pexa-Vec in Second-Line Advanced Liver Cancer Did Not Meet Its Primary Endpoint

September 3, 2013
·
2 min read
Policy

China Police: Crimes Were Organized by GlaxoSmithKline, Not Individual Staffers

September 3, 2013
·
1 min read
Drug Development

Isis Pharmaceuticals, Inc.'s Experimental Heart Drug Leads to Big Reduction in Blood Fat in Phase 2 Study; Stock Up +3.48% at Market Close (September 3, 2013)

September 3, 2013
·
7 min read
Drug Development

TRANSGENE’s TRAVERSE Phase 2 Study Fails to Meet Main Goal

September 3, 2013
·
5 min read
Business

Newly Named VIVUS, Inc. CEO Resigns Due to Health Concerns, Ex-Johnson & Johnson Exec to Take Over

September 3, 2013
·
4 min read